Targeting hypoxic cancer stem cells (CSCs) with Doxycycline: Implications for optimizing anti-angiogenic therapy-Reference-Cited by-同舟云学术

Targeting hypoxic cancer stem cells (CSCs) with Doxycycline: Implications for optimizing anti-angiogenic therapy

Published:2017-06-12 Issue:34 Volume:8 Page:56126-56142
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

De Francesco Ernestina Marianna¹²,Maggiolini Marcello¹,Tanowitz Herbert B.³,Sotgia Federica⁴,Lisanti Michael P.⁴

Affiliation:

1. Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende, Italy

2. The Paterson Institute, University of Manchester, Withington, United Kingdom

3. Departments of Pathology and Medicine, Albert Einstein College of Medicine, Bronx, NY, USA

4. Translational Medicine, School of Environment and Life Sciences, Biomedical Research Centre (BRC), University of Salford, Greater Manchester, United Kingdom

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Density Gradient Centrifugation is an Effective Tool to Isolate Cancer Stem-Like Cells from Hypoxic and Normoxia Triple-Negative Breast Cancer Models;International Journal of Molecular Sciences;2024-08-17

2. The critical role of glutamine and fatty acids in the metabolic reprogramming of anoikis-resistant melanoma cells;Frontiers in Pharmacology;2024-08-08

3. Metabolic adaptations in cancer stem cells: A key to therapy resistance;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-06

4. Immunotherapeutic Strategies Targeting Breast Cancer Stem Cells;Current Oncology;2024-05-29

5. Doxycycline treatment modulates the immune response of tilapia and controls Aeromonas hydrophila infection;Aquaculture;2024-03